Navigation Links
Dysport Available! New Wrinkle Treatment in Washington, DC Offers Botox Alternative
Date:6/19/2009

WASHINGTON, June 19 /PRNewswire/ -- The Center for Laser Surgery, Washington, DC has announced the availability of Dysport, abobotulinum toxin-A. Dysport, recently FDA approved, is the first cosmetic neurotoxin available alongside the widely used BOTOX(R) Cosmetic (botulinum toxin-A).

The Center for Laser Surgery was principal investigator of the FDA Stage III Clinical Trials for Dysport. As Washington, DC, Maryland and Virginia's largest and most experienced Botox practice, the center was honored to be the sole Dysport investigator in DC.

Dysport is a simple, effective, non-surgical treatment that works by relaxing facial muscles, thereby reducing and smoothing away frown-lines and wrinkles. Dysport, like Botox, is a protein extracted from the bacterium Clostridium Botulinum. Dysport has been available in Europe, Asia and South America for over 10 years. Dysport is manufactured by Ipsen Pharmaceuticals (FRA) and distributed in the United States by Medicis, manufacturer of the Restylane dermal filler.

Many cosmetic physicians outside the U.S. who have used Dysport report faster action and greater longevity for Dysport when compared to Botox. In most unbiased neurological studies for the treatment of movement disorders, Dysport has provided equal or greater efficacy when used in a 2.5 to 4:1 ratio to Botox. In a double-blinded randomized crossover study in cervical dystonia (the most common use of neurotoxins in the world), results showed Dysport to be more effective than Botox with a similar safety and side effect profile when used in a 3:1 dose relationship.

In 2006, Dr. Robert M. Adrian, founder of the Center for Laser Surgery, sponsored and fully funded a 24-patient double blinded comparative study of Dysport and Botox in the treatment of forehead
'/>"/>

SOURCE The Center for Laser Surgery
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dysport Added as a Procedure on AmericanHealthandBeauty.com: Let the Wrinkle Wars Begin
2. New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble
3. MultiVu Video Feed: Save Your Knees! Treatments Are Available!
4. Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
5. New Option for Erasing Wrinkles
6. Zatik Organic Beauty Care Lunch Seaweed-Herbal Wrinkle Reduction and Natural Skin Whitening Products
7. Anti-aging cosmetic reduced wrinkles in clinical trial
8. Botox(R) vs. Reloxin(R) -- the Wrinkle Titans Poised for Battle
9. Wrinkles on the Rise Due to the Economy
10. Wrinkle Cream Reviews Site Reveals a Winner for 2008's Best Wrinkle Creams : Wrinkle Cream reviewssite, WrinkleBest.com has released the Editor's Choice for Best Wrinkle Cream of 2008
11. Wrinkle Fillers Need Better Label Warnings: FDA Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Latin American ... the market with analysis and forecast of revenue. The poultry ... to grow from $25,273.3 million and $647.2 million in 2013 ... CAGR of 6.1% from 2013 to 2018, respectively. , To ... browse through the TOC of the Latin American poultry feed ...
(Date:7/29/2014)... July 29, 2014 Frank Davis, Activz ... can help parents add nutrition to their kids’ meals ... – Key market drivers in kids’ foods market” by ... pleased to announce the interview Frank Davis had with ... Activz organic vegetable and fruit produce powders to kids ...
(Date:7/29/2014)... News) -- Decorative contact lenses may seem like a ... cause serious eye damage. Decorative contacts should be ... the U.S. Food and Drug Administration (FDA). It,s important ... for these lenses and buy them from a trustworthy ... about the potential health risks associated with decorative contact ...
(Date:7/29/2014)... including Penn State College of Medicine, have jointly ... a health data research network., The Patient-Centered Outcomes ... Patient Protection and Affordable Care Act, awarded the ... University and Johns Hopkins University -- and each ... have come together to create a Clinical Data ...
(Date:7/29/2014)... July 29, 2014 – Silverado, a provider of memory ... that it is a Bronze winner in the 35th Annual ... Through a Child's Eye and Silverado Resident Visits ... a Child's Eye , seven-year-old Mia Sandoval shares her experience ... a memory care community in Los Angeles. The feel-good video ...
Breaking Medicine News(10 mins):Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:It's 'Buyer Beware' for Decorative Contact Lenses, FDA Says 2Health News:New network unites university health care research 2Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2
... research suggests , THURSDAY, July 30 (HealthDay News) -- ... in patients with head and neck cancer, U.S. researchers ... black Americans, who have far less HPV infection than ... , "There is currently no consensus on why blacks ...
... , , YOUNTVILLE, Calif., July 30 ... , WHAT: A special hearing of the California Senate Veterans ... The hearing was originally , scheduled for Friday, July 31, 2009 ... , , , ...
... , PASADENA, Calif., July ... announced its licensee, BioMS Medical Corp., and Eli Lilly ... primary endpoint of delaying disease progression, as measured by ... Phase III trial in patients with secondary progressive multiple ...
... , , EATONTOWN, N.J., July 30 Osteotech, ... field of biologic products for regenerative healing, announced today that its ... 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel ... (EDT). , , A live, listen-only webcast of ...
... , , NEW YORK, July ... results for the three months ended June 30, 2009. , , ... revenue grew by 18% as we see continuing demand from both pharmaceutical as ... Gattinella, President and CEO. "I am enthusiastic about the momentum we are gaining ...
... , , , WASHINGTON, July ... private, employer-based coverage if Congress passes a House health reform bill, ... Choices Act of 2009 released this week by ... Heritage commissioned The Lewin Group , a ...
Cached Medicine News:Health News:Virus May Affect Survival in Head and Neck Cancer 2Health News:Clinical Trial by Licensee Does Not Meet Primary Endpoint 2Health News:WebMD Announces Second Quarter Financial Results 2Health News:WebMD Announces Second Quarter Financial Results 3Health News:WebMD Announces Second Quarter Financial Results 4Health News:WebMD Announces Second Quarter Financial Results 5Health News:WebMD Announces Second Quarter Financial Results 6Health News:WebMD Announces Second Quarter Financial Results 7Health News:WebMD Announces Second Quarter Financial Results 8Health News:WebMD Announces Second Quarter Financial Results 9Health News:WebMD Announces Second Quarter Financial Results 10Health News:WebMD Announces Second Quarter Financial Results 11Health News:WebMD Announces Second Quarter Financial Results 12Health News:WebMD Announces Second Quarter Financial Results 13Health News:WebMD Announces Second Quarter Financial Results 14Health News:WebMD Announces Second Quarter Financial Results 15Health News:WebMD Announces Second Quarter Financial Results 16Health News:WebMD Announces Second Quarter Financial Results 17Health News:WebMD Announces Second Quarter Financial Results 18Health News:WebMD Announces Second Quarter Financial Results 19Health News:Thousands of Nebraskans Could Lose Private Insurance, Study Shows 2
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
(Date:7/28/2014)... , July 28, 2014  Dignity Health St. ... received the Get With The Guidelines®-Stroke Silver-Plus Quality ... outlined by the American Heart Association/American Stroke Association ... the number four cause of death and a ... the United States , according to the ...
(Date:7/28/2014)... , July 28, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... second quarter results and conference call with investors to ... 30, 2014.  The Company rescheduled the release date and ... funeral services for Hideo Watanabe , President of ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2
... K-V Pharmaceutical Company ( KVa; KVb) (the "Company") ... HOLX ) that site initiation and patient enrollment has ... in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 ... of preterm birth in women pregnant with a single baby ...
... The Wireless-Life Sciences Alliance (WLSA) , which convenes innovators, globally relevant ... in wireless technologies, today hailed its partner organizations for their collaboration and ... , , ... , , ...
Cached Medicine Technology:K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 2K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 3K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 4K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 5K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 6K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 7K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 8K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 9Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 2Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 3
... Drug Interaction Principles is the number one ... , An understanding of drug interactions has ... Since publication of the first edition of ... pharmacopoeia - coupled with prolonged human life ...
... drug information reference that integrates ... patient care guidelines., The sixth ... 4,700 drugs, including the latest ... indications, dosages, side effects and ...
Updated for 2006 with more than 800 complete drug entries, this mobile reference provides instant access to all the drug information nurses need in day-to-day practice....
... ACM-8 loads and unloads two centrifuges with ... via Cap Recognition the tube type is ... batches of three 5 position racks into ... single centrifuge ACM can be offered for ...
Medicine Products: